ArticleJournal of functional biomaterials2026
Tetracalcium Phosphate Graft for Implant Stabilization: Resonance Frequency and Histomorphometric Analysis in a Sheep Tibia Model.
Article in Journal of functional biomaterials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundThis study aimed to evaluate the effects of tetracalcium phosphate (TTCP) graft material on the stability and osseointegration of dental implants placed in anatomically compromised bone. MATERIALS AND
methodsSix healthy sheep were used following ethical approval. Osteotomies were created in the tibial region and divided into three groups: Group A (control,
resultsInitial RFA values exceeded 42.5 in all groups. Group C demonstrated the highest RFA at Week 6 (79) and significantly higher RFA values at Week 3 compared to other groups, while Group B consistently showed the lowest stability. At Week 3, Group A exhibited the highest BIC% (28.04 ± 5.05%). By Week 6, BIC% increased in all groups, with no significant intergroup differences. Robust ANOVA revealed significant effects of time and group on both RFA and BIC%.
conclusionsTTCP significantly enhanced implant stability and osseointegration in compromised bone, providing improved secondary stability and suggesting its potential clinical benefit in challenging anatomical conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.